Concepedia

Publication | Open Access

Phase I trial of dimethyl fumarate, temozolomide, and radiation therapy in glioblastoma

DOIFull Paper Access

23

Citations

8

References

2020

Year

Danielle Shafer, Mary Beth Tombes, Ellen Shrader, Alison A. Ryan, Dipankar Bandyopadhyay, Paul Dent, Mark G. Malkin
Neuro-Oncology Advances

Abstract

DMF may be safely combined with RT and TMZ in patients with newly diagnosed GBM. The RP2D for DMF is 240 mg three times daily.

References

YearCitations

Page 1